Squibb Cephalosporins : SQ11,436 and SQ11,437— External Report to the SquibbInstitute for Medical Research. June 27, 1969.
2.
Report of the Two-Week Safety and Drug Accumulation Study with Cephradine. Division of Medical Affairs, the Squibb Institute for Medical Research, January 27, 1971.
3.
Weliky, I., and Zaki, A.: Absorption, distribution, and elimination of cephradine after oral and parenteral administration to humans. In: Cephradine, a New Broad Sepctrum Antibiotic. Excerpta Medica: 1-5, 1974 (Selected Proceedings from the 8th International Congress of Chemotherapy, September 8 to 14, Athens, Greece.)
4.
Thurman, W.G. : Utilization of cephradine for suspension in paediatric infections. J. Irish Med. Assoc. [Suppl.]66: 31, 1973.
5.
Rosenberg, B. , et al.: Cephradine in the treatment of paediatric infections. J. Int. Med. Res.2: 350, 1974.
6.
Alban, J., and Caloza, D.L.: Cephradine and cephalexin in the treatment of children with bacterial pneumonia . Cur. Ther. Res.18: 539, 1975.
7.
Bauer, A.W., Kirby, W.M.M., et al.: Antibiotic susceptibility testing by a standardized single disc method. Am. J. Clin. Pathol.45: 493, 1966.